'It's not about money, it's about my health': Determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South Africa

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 579-588

  MacPhail, Catherine ^a   Delany Moretlwe, Sinead ^a   Mayaud, Philippe ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Adherence; HIV prevention; South Africa; Trial

Indexed keywords

ACICLOVIR; PLACEBO;

ADULT; AGE; ALTRUISM; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; FEMALE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HELP SEEKING BEHAVIOR; HERPES SIMPLEX VIRUS 2; HERPES VIRUS INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MIXED INFECTION; MOTIVATION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; SERODIAGNOSIS; SOUTH AFRICA; TREATMENT CONTRAINDICATION;

EID: 84880354168     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S30759     Document Type: Article

References (24)

1. Weiss H, Wasserheit J, Barnabas R, Hayes R, Abu-Raddad L. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008;5:8.
2. Colfax G, Buchbinder S, Vamshidar G, et al. Motivations for participation in an HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:359-364.
3. Tharawan K, Manopaiboon C, Ellertson C, et al. Women's willingness to participate in microbicide trials in Northern Thailand. J Acquir Immune Defic Syndr. 2001;28:180-186.
4. Kenyon S, Dixon-Woods M, Jackson C, Windridge K, Pitcheforth E. Participating in a trial in a critical situation: a qualitative study in pregnancy. Qual Saf Health Care. 2006;15:98-101.
5. Shaffer D, Yebei V, Ballidawa J, et al. Equitable treatment for HIV/AIDS clinical trial participants: a focus group study of patients, clinical researchers, and administrators in western Kenya. J Med Ethics. 2006;32:55-60.
6. Padian N, Buve A, Balkus J, Serwadda D, Cates W Jr. Biomedical interventions to prevent HIV infection: evidence, challenges and way forward. Lancet. 2008;372:585-599.
7. Watson-Jones D, Baisley K, Rusizoka M, et al. Measurement and predictors of adherence in a trial of HSV suppressive therapy in Tanzania. Contemp Clin Trials. 2009;30:504-512.
8. Mauck CK, Straten A. Using objective markers to assess participant behavior in HIV prevention trials of vaginal microbicides. J Aquir Human Immune Defic Syndr. 2008;49:64-69.
9. Delany S, Mlaba N, Clayton T, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009;23:461-469.
10. Pope S, Ziebland S, Mays N. Qualitative research in health care: analyzing qualitative data. BMJ. 2000;320:114-116.
11. Strauss A, Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques. Thousand Oaks, CA: Sage Publications; 1990.
12. Straus SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984;310:1545-1550.
13. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984;310:1551-1556.
14. Gupta A, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis. 2004;190:1374-1381.
15. Delany S, Mlaba N, Clayton T, et al. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009;23:461-469.
16. Jewkes R, Abrahams N, Mvo Z. Why do nurses abuse patients? Reflections from South African obstetric services. Soc Sci Med. 1998;47:1781-1795.
17. Wood K, Jewkes R. Blood blockages and scolding nurses: barriers to adolescent contraceptive use in South Africa. Reprod Health Matters. 2006;14:109-118.
18. Stadler JJ, Delany S, Mntambo M. Women's perceptions and experiences of HIV prevention trials in Soweto, South Africa. Soc Sci Med. 2008;66:189-200.
19. Stirratt M, Christopher C. Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS Rep. 2008;5:186-192.
20. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52:1143-1156.
21. Sarkar N. Barriers to condom use. Eur J Contracept Reprod Health Care. 2008;13:114-122.
22. van der Straten A, Cheng H, Moore J, et al; MIRA Team. The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav. 2008;13:564-572.
23. Wendler D, Krohmal B, Emanuel E, Grady C. Why patients continue to participate in clinical research. Arch Intern Med. 2008;168:1294-1299.
24. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-895.